- Home
- SLXN vs ASST Comparison
SLXN vs ASST Comparison
Compare SLXN & ASST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLXN
- ASST
- Stock Information
- Founded
- SLXN 2008
- ASST 2020
- Country
- SLXN Israel
- ASST United States
- Employees
- SLXN N/A
- ASST N/A
- Industry
- SLXN
- ASST Computer Software: Prepackaged Software
- Sector
- SLXN
- ASST Technology
- Exchange
- SLXN NYSE
- ASST Nasdaq
- Market Cap
- SLXN 6.9M
- ASST 7.2M
- IPO Year
- SLXN N/A
- ASST 2023
- Fundamental
- Price
- SLXN $0.93
- ASST $0.60
- Analyst Decision
- SLXN Strong Buy
- ASST
- Analyst Count
- SLXN 1
- ASST 0
- Target Price
- SLXN $5.00
- ASST N/A
- AVG Volume (30 Days)
- SLXN 3.6M
- ASST 559.9K
- Earning Date
- SLXN 05-21-2025
- ASST 05-14-2025
- Dividend Yield
- SLXN N/A
- ASST N/A
- EPS Growth
- SLXN N/A
- ASST N/A
- EPS
- SLXN N/A
- ASST N/A
- Revenue
- SLXN N/A
- ASST $633,489.00
- Revenue This Year
- SLXN N/A
- ASST N/A
- Revenue Next Year
- SLXN N/A
- ASST N/A
- P/E Ratio
- SLXN N/A
- ASST N/A
- Revenue Growth
- SLXN N/A
- ASST 128.66
- 52 Week Low
- SLXN $0.21
- ASST $0.34
- 52 Week High
- SLXN $13.56
- ASST $3.94
- Technical
- Relative Strength Index (RSI)
- SLXN N/A
- ASST 58.53
- Support Level
- SLXN N/A
- ASST $0.50
- Resistance Level
- SLXN N/A
- ASST $0.61
- Average True Range (ATR)
- SLXN 0.00
- ASST 0.06
- MACD
- SLXN 0.00
- ASST 0.01
- Stochastic Oscillator
- SLXN 0.00
- ASST 97.16
About SLXN BIOMOTION SCIENCES
Silexion Therapeutics Corp a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for KRAS-driven cancers. The KRAS gene is an oncogene that is involved in the regulation of cell division as a result of its ability to relay external signals into the cell. Its product candidate, SIL204, consists of locally administered small interfering RNAs, or siRNA, in a solution, as a first-line treatment of locally advanced pancreatic cancer patients, or LAPC, in combination with standard-of-care chemotherapy. It is currently focused on treatment for pancreatic cancer tumors bearing the KRAS G12D or KRAS G12V mutations where metastases have not been detected and are non-resectable, i.e. it is not able to be surgically removed.
About ASST Asset Entities Inc. Class B
Asset Entities Inc is an Internet company providing social media marketing, content delivery, and development and design services across Discord, TikTok, and other social media platforms. It has three categories of services: 1) provide subscription upgrades to premium content on investment education and entertainment servers on Discord. 2) codevelop and execute influencer social media and marketing campaigns for clients. 3) design, develop and manage Discord servers for clients under "AE.360.DDM" brand.